• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    Rigel Pharmaceuticals, Inc. (RIGL)

    -NasdaqGS
    2.15 Down 0.06(2.71%) Jan 27, 4:00PM EST
    |After Hours : 2.15 0.00 (0.00%) Jan 27, 4:50PM EST
    Add to Portfolio
    Prev Close:2.21
    Open:2.17
    Bid:N/A
    Ask:2.44 x 500
    1y Target Est:6.50
    Beta:1.88
    Next Earnings Date:N/A
    Day's Range:2.14 - 2.25
    52wk Range:1.56 - 5.00
    Volume:186,262
    Avg Vol (3m):498,615
    Market Cap:188.75M
    P/E (ttm):N/A
    EPS (ttm):-0.98
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    RIGLDown 2.71%188.75M
    AMGNDown 0.53%120.86B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):33.74
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.04
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback